* Said on Tuesday, U.S. FDA approves Soliqua 100/33 for treatment of adults
with type 2 diabetes
The post BRIEF-Zealand Pharma: US FDA approves Soliqua 100/33 for treatment of adults with type 2 diabetes appeared first on NASDAQ.
BRIEF-Zealand Pharma: US FDA approves Soliqua 100/33 for treatment of adults with type 2 diabetes
